U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838220) titled 'A Study of IBI3016 in Japanese Participants' on Sept. 13.
Brief Summary: A phase I clinical study to evaluate the safety ,tolerability, pharmacokinetic and pharmocodynamic characteristics of a single subcutaneous does of IBI3016 in Japanese participants with mild to moderate hypertension.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: IBI3016 Dose 4
single doses of IBI3016 administered by subcutaneous injection
DRUG: IBI3016 Dose 3
single doses of IBI3016 administered by subcutaneous injection
DRUG: IBI3016 Dose 2
single doses of IBI3016 administered by subcutaneous injec...